A carregar...
Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma,...
Na minha lista:
| Publicado no: | Case Rep Oncol Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5822822/ https://ncbi.nlm.nih.gov/pubmed/29593922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4273231 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|